Showing results (51-60 of 101) with videos related to
Sort By:
Pageof 11
Nature Communications|March 29, 2023
Histone demethylase KDM2A is a selective vulnerability of cancers relying on alternative telomere maintenanceFei Li, Yizhe Wang, Inah Hwang, et al.Biorxiv : the Preprint Server for Biology|February 17, 2023
Histone demethylase KDM2A is a selective vulnerability of cancers relying on alternative telomere maintenanceFei Li, Yizhe Wang, Inah Hwang, et al.American Journal of Cancer Research|April 13, 2017
A tumor vessel-targeting fusion protein elicits a chemotherapeutic bystander effect in pancreatic ductal adenocarcinomaChun-Te Chen, Yi-Chun Chen, Yi Du, et al.Nature Communications|February 25, 2017
Mutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal adenocarcinomaHuai-Qiang Ju, Haoqiang Ying, Tian Tian, et al.JCI Insight|July 24, 2019
Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancerMeifang Yu, Nicholas D Nguyen, Yanqing Huang, et al.Nature|March 29, 2013
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathwayJaekyoung Son, Costas A Lyssiotis, Haoqiang Ying, et al.Cancer Cell|May 19, 2010
PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomasHongwu Zheng, Haoqiang Ying, Ruprecht Wiedemeyer, et al.Biorxiv : the Preprint Server for Biology|October 4, 2023
KRAS inhibition activates an actionable CD24 'don't eat me' signal in pancreas cancerYongkun Wei, Minghui Liu, Er-Yen Yen, et al.Cell Reports. Medicine|February 18, 2026
Syndecan-1-targeted therapeutic antibody impairs macropinocytosis and elicits antitumor immunity in pancreatic cancerZecheng Yang, Madelaine S Theardy, Shuaitong Chen, et al.Proceedings of the National Academy of Sciences of the United States of America|March 31, 2010
Mig-6 controls EGFR trafficking and suppresses gliomagenesisHaoqiang Ying, Hongwu Zheng, Kenneth Scott, et al.Pageof 11